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Introduction
BCR-ABL1 negative chronic myeloproliferative neoplasms
(CMPNs) are a heterogeneous group of clonal haematological 
malignancies characterised by abnormal proliferation and 
survival of one or more myeloid lineage cells. Over the last 
years, some genetic alterations (translocations, amplifications 
or point mutations) have been described, most of them 
activating tyrosine kinases (TKs). However, there is still a 
significant proportion of patients in which the molecular lesion
causing the disease remains to be discovered. The involvement 
of some TK genes and the success of the targeted anti-TK 
therapy point to these genes as good candidates for systematic 
screenings in these diseases
In this study, we used FISH to search putative cryptic 
rearrangements of all genes from the families III (PDGFRA, 
PDGFRB, CSF1R, KIT and FLT3) and IV (FGFR1, FGFR2, FGFR3
and FGFR4) of receptor-TKs, as well as all genes from the 
families Jak (JAK1, JAK2, JAK3 and TYK2), Abl (ABL1 and 
ABL2) and Syk (SYK and ZAP70) of cytoplasmic-TKs. All of 
them code for proteins with tyrosine kinase activity and some 
of them have been found mutated in CMPNs and in other tumor
types
We obtained samples from 44 
caucasian CMPN patients with 
normal karyotype (28 males and 16 
females), four diagnosed with 
polycythaemia vera (PV), four with 
idiopathic myelofibrosis (IMF), 15 
with essential thrombocythemia (ET) 
and 21 with atypical MPN (aCMPN-). 
BCR-ABL1 fusion and V617FJAK2
mutation were ruled out by 
conventional analyses (RT-PCR/FISH 
and ARMS-PCR respectively). 
Material for all tests was only 
available for 27 of the 44 patients 
We designed two-colour FISH 
analyses with flanking probes using 
BAC clones according to the position 
showed by UCSC Genome Browser
(http://genome.ucsc.edu) (Table). 
Clones were obtained from BACPAC 
Resources Center at Children´s
Hospital Oakland Research Institute
(Oakland, CA) and Clone Resources
at The Welcome Trust Sanger 
Institute (Hixton, UK)
Some of the TK genes selected for 
the analyses have been found fused 
with ETV6 (12p13), so we included 
an analysis of this gene (with Vysis
LSI ETV6 Dual Color Breakapart
Probe from Abbott Molecular, Abbott 
Park, IL) in order to check if 
abnormalities in ETV6 could unravel 
new TK fusions
Materials & methods
Every probe was initially validated on normal samples to verify 
the correct hybridization and to establish a cut-off value of 
abnormal signals on interphase normal nuclei 
For PDGFRA, we observed an abnormal FISH pattern with 
gene-flanking probes in an aCMPN patient (15081). Whereas 
the normal hybridization pattern would be two green-red 
fusion signals, this patient lost the red signal in 85% 
(170/200) of the nuclei and 8/10 of the metaphases analyzed. 
This pattern suggested a deletion of the 5´ part of the gene. 
An assay with a commercial FISH probe (QBiogene, Irvine, 
CA) to check this results, showed a pattern compatible with a 
FIP1L1-PDGFRA type of rearrangement, not detected by 
conventional RT-PCR
All other samples showed normal hybridization patterns for all 
the TK genes and ETV6
A1. Metaphase FISH PDGFRA analysis with flanking probes. Although normal hybridization 
pattern would be two red-green fusion signals, we observed one red-green fusion signal 
from normal chr4 and an extra green signal from der(4) (white arrows). This pattern 
reveals a deletion of the 5´ upstream part of PDGFRA
A2. Light microscopy of the same metaphase as in A1
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Results
• FISH analysis of genes from TK families (PDGFRA, PDGFRB, 
CSF1R, KIT, FLT3, FGFR1, FGFR2, FGFR3, FGFR4, JAK1, JAK2, 
JAK3, TYK2, ABL1, ABL2, SYK and ZAP70) did not show any 
new cryptic chromosomal rearrangement
• Only in one patient a FIP1L1-PDGFRA fusion was detected that 
had been missed by conventional RT-PCR, confirming that 
FISH analysis, as other groups have shown, is a good 
technique to detect the FIP1L1-PDGFRA gene fusion
when conventional RT-PCR fails due to the variability of 
breakpoints in FIP1L1
• Rearrangements affecting these genes are very infrequent 
events in BCR-ABL1 negative chronic myeloproliferative
neoplasms (CMPNs) 
Conclusions
FISH analysis with non-commercial flanking probes on nuclei and metaphases when
available. All cases show a normal hybridization pattern with two fusion red-green
signals, one for each chromosome. A FGFR1 assay. B FGFR2 assay. C FGFR3 assay. D
FGFR4 assay. E SYK assay. F ZAP70 assay.
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